Key clinical point: New data suggest physicians and patients both overestimate control of severe asthma.
Major finding: More than half (53%) of cases physicians rated as controlled were actually uncontrolled according to the Asthma Control Test, and 30% of patients who considered their asthma controlled actually were uncontrolled according to the test.
Study details: Observational study of 482 evaluable subjects
Disclosures: The study is supported by AstraZeneca. Dr. Panettieri disclosed relationships with AstraZeneca, Sanofi, Regeneron, Genentech, and Novartis.
Panettieri R et al. CHEST 2019. Abstract, doi. 10.1016/j.chest.2019.08.272.